Clinical trial

Pharmacokinetics of Low Dose Raltegravir

NCT01159132

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-04-01

PhasePHASE2

Study timeline

Study start (unknown)2010-04-01Date precision: month

Registry last updated2020-07-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

raltegravirDRUG · verified · RxNorm: raltegravir

Sponsors & collaborators

The HIV Netherlands Australia Thailand Research Collaborationlead sponsor

National Healthcare Group Pte Ltd, Singaporecollaborator

Chulalongkorn Universitycollaborator

Mapped research locations

BangkokThailand1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01159132 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.